April 25th-26th, 2025

ON-SITE CONFERENCE

Hotel Polonia Palace

Al. Jerozolimskie 45 | Warsaw

      Dear Sirs

I am pleased to invite you to participate in the Polish Liver Summit scheduled at April 25th-26th, 2025 at beautiful capital of Poland, Warsaw.

The liver summit provides a unique opportunity to hear from leading experts in liver research about the latest advancements in liver disease, particularly diagnostics, therapeutics, and patient care. It’s a great chance to meet with other professionals in the field and explore new collaborations. However our main goal of the first day of our conference is to celebrate huge advance in HCV therapy and discuss the need for national elimination of HCV infection, share experiences from other countries and try to establish activities necessary to reach WHO 2030 goal. We hope many Polish authorities will join us in this very important discussion. The second day will be dedicated to metabolic-associated steatotic liver disease and advances in less frequent liver diseases, including HDV infection and PBC. We will focus on diagnostic challenges and need for non-invasive methods.

Moreover, your knowledge will be enhanced by Warsaw, an amazing city with long history, delicious Polish and international cuisine, and modern culture. We hope that Polish Liver Summit 2025 will be a fantastic experience.

We look forward to meeting you in Warsaw.


prof. dr hab. n. med.
Krzysztof Tomasiewicz

Scientific Direction

Krzysztof Tomasiewicz

prof. dr hab. n. med.

Head of the Department and Clinic of Infectious Diseases at the University Clinical Hospital No. 1 in Lublin
President of the Polish Society of Epidemiologists and Infectious Disease Physicians

Scientific Program

Polish Liver Summit 2025

How far are we from WHO HCV Elimination 2030 goals with 10 years of revolutionary treatments?

Conference of Polish Hepatology Expert’s Group

April 25th ,2025

12.00 – 13.05    I OPENING SESSION

  • 12.00 – 12.10
    Opening and Introduction
    –Prof. Krzysztof Tomasiewicz, Head of HCV Polish Experts Group
  • 12.10 – 12.30
    Global Status and Poland’s National Elimination Profile for HCV
    – Dr. John Ward, Director, Coalition for Global Hepatitis Elimination
  • 12.30 – 12.40
    System Role of the Supreme Medical Chamber in HCV Elimination
    – Łukasz Jankowski, Head of Supreme Medical Chamber in Poland
  • 12.40 – 12.50
    Cost Effectiveness of Universal HCV Screening Strategies in Poland
    – Anna Kowalczuk, Agency for Health Technology Assessment and Tariff
  • 12.50 – 13.05
    Decade of Revolutionary HCV Treatment & Importance of Short Treatment Duration – sponsored by
    – Prof. Robert Flisiak

13:05 – 14:05    II SESSION: Key Learnings on National Screening Programs in EUROP

Moderator: Prof. Jerzy Jaroszewicz, Prof. Anna Piekarska

  • 13.05 – 13.20
    Best Practices from Germany
    – Prof. Florian van Bömmel, UNIVERSITÄTSKLINIKUM LEIPZIG
  • 13.20 – 13.35
    Hospital Screening Project in Spain (DECALOG)
    – Prof. Maria Buti, Hospital General Universitario Valle Hebron, Barcelona
  • 13.35 – 13.50
    Elimination of HCV in Spanish Prisons and PWIDs
    – Prof. Rafael Esteban, Hospital General Universitario Valle Hebron, Barcelona
  • 13.50 – 14.05
    National HCV Screening Program in Lithuania
    – Prof. Limas Kupčinskas, Lithuanian University of Health

14:05 – 14:20 COFFEE BREAK

14:20 – 15:20  Experts Debate Panel Discussion: Enhancing and Developing Poland’s HCV Elimination Program

Moderator: Michał Dobrołowicz

Participants:

    • Maciej Karaszewski – Director, Department of Medical Services, Ministry of Health (TBC)
    • Prof. Miłosz Parczewski – National Consultant
    • Beata Małecka-Libera – Senator
    • Anna Kowalczuk – Agency for Health Technology Assessment and Tariff System (AOTMiT)
    • Krzysztof Bojarski – Member of Parliament, Health Committee (TBC)
    • Wodzisław Giziński – Member of Parliament, Health Committee (TBC)
    • Filip Nowak – National Health Found
    • Magdalena Władysiuk – Central and Eastern European Society of Technology Assessment in Health Care (CEESTAHC)

15:20 – 16:30    III SESSION: Screening Strategy for Integrating HCV as a Multisystemic Disease

Moderator: Prof. Małgorzata Pawłowska, Prof. Robert Flisiak

  • 15.20 – 15.30
    Oncological Perspectives in HCV Screening
    – Prof. Dawid Murawa
  • 15.30 – 15.40
    Transplantology’s Role in HCV Management
    – Prof. Maciej Kosieradzki
  • 15.40 – 16.30
    Experts Debate Panel Discussion: Multifaceted Approach to the HCV Virus and Its Impact on Various Fields of Medicine and Public Health

Participants

    1. Justyna Mieszalska – Head of Medical Centre WUM Sp. z o.o.
    2. Konrad Korbiński – Department of Coordination Oncology Care, MoK
    3. Prof. Dawid Murawa – Department of Surgery and Oncology, Medical College of the University of Zielona Góra
    4. Bernard Waśko – National Institute of Public Health – NIH
    5. Dr n. med. Marcin Rybacki – IMP – Nofer Institute of Occupational Medicine

16.30 – 16.45 COFFEE BREAK

16:45 – 18:00    IV SESSION: Key Learnings on HCV Elimination in Prisons in Europe

Moderator: Prof. Krzysztof Tomasiewicz, Dr. Anna Bogusławska Marzec – National AIDS Centre

  • 16.45 – 17.00
    Evaluation of Prisoner Projects in the Czech Republic
    – Dr. Vratislav Rehak
  • 17.00 – 17.10
    Challenges and Achievements in HCV Management in Polish Prisons
    – Monika Jakubowska
  • 17.10 – 18.00 Discussion
    1. Dagmara Korbasińska-Chwedczuk, Department of Public Health, Ministry of Health (TBC)
    2. Monika Jakubowska
    3. Wojciech Konieczny – Ministry of Health (TBC)

18.00 – 18.15 COFFEE BREAK

18:15 – 19:00    V SESSION: Role of Patient Associations in HCV Elimination

Moderator: Prof. Dorota Zarębska Michaluk, Magdalena Ankiersztejn-Bartczak

  • 18.15 – 18.30 Activation of Patient Advocacy in Greece
    – George Kalamitsis, Hellenic Liver Patient Association „Prometheus”
  • 18.30 – 19.00   Discussion:
    • Barbara Pepke – Hope Star Foundation
    • Sebastian Gawlik – Pan Wątroba
    • Urszula Jaworska – Urszula Jaworska Foundation
    • Zenon Jasyk – Podwale 7
    • Marzanna Bińkowska – Patient Rights Ombudsman

19.00    Closing
– Prof. Krzysztof Tomasiewicz

20.00    Gala Dinner (Conference Room Polonia Palace)

April 26th ,2025

09.00 – 10.10    I SESSION: MASLD and liver diseases diagnostics

Moderator: Prof. Marta Wawrzynowicz Syczewska, Prof. Michał Kukla

  • 09.00 – 09.15
    How to optimize HCC surveillance? – sponsored by
    – Prof. Jerzy Jaroszewicz
  • 09.15 – 09.30
    Experiences in HCC diagnostics using biomarkers – sponsored by
    – Asst. prof. Sanja Stanković (Serbia)
  • 09.30 – 09.45
    Monitoring of liver cirrhosis – what to do to be aware of consequences
    – Prof.  Marta Wawrzynowicz-Syczewska
  • 09.45-10.00
    MASLD in children – clinical and epidemiological aspects
    – Prof. Małgorzata Pawłowska
  • 10.00 – 10.10 Discussion

10:10 – 10:25 COFFEE BREAK

10.25 – 11.35 II SESSION: Rare/not diagnosed liver diseases

Moderator: Prof. Anna Piekarska, Prof. Jerzy Jaroszewicz

• 10.25 – 10.40
PBC – diagnostic and therapeutic perspective – sponsored by
– Prof. Michał Kukla

• 10.40 – 10.55
HDV – shall we screen all HBV infected patients
– Prof. Dorota Zarębska-Michaluk

• 11.55 -11.10
HCC – how to avoid and treat
– Prof. Marek Pacholczyk

• 11.10-11.25
Hepatic encephalopathy – diagnosis and treatment at different stages of disease
– Prof. Anatol Panasiuk

• 11.25 – 11.50 Discussion

11:35 – 11:50 COFFEE BREAK

11.50 – 13.20 III SESSION: MASLD

Moderator: Dr Andrzej Gietka, Prof. Krzysztof Tomasiewicz

• 11.50 – 12.05
New nomenclature of steatosis liver disease – impact on everyday clinical practice
– Prof. Anna Piekarska

• 12.05 – 12.20
Risk groups of MASLD and how to screen them
– Dr Gabrielė Milaknytė, Vilnius University Santaros Clinics

• 12.20 – 12.35
Cardiovascular disease and MASLD
– Prof. Filip Szymański

• 12.35 – 12.50
Do we have any treatment for MASH – sponsored by 
– Dr n. med. Jakub Klapaczyński

• 12.50 – 13.10
Future of MASLD specific therapy – sponsored by 
– Prof. Krzysztof Tomasiewicz

• 13.10 – 13.20 Discussion

  • 13.20 – 13.30 Closing
    – Prof. Krzysztof Tomasiewicz

13:30  LUNCH

Sponsors

MAIN SPONSOR

LEADING SPONSOR

SUPPORTING SPONSORS 

PATRONAGE

Regulations

REGULATIONS of the Conference „Polish Viral Hepatitis Summit 2025”

25-26.04.2025

General Provisions
The Organizer of the Conference „Polish Viral Hepatitis Summit 2025”, which will take place on 25-26.04.2025 (hereinafter: „Conference”) is the company 90Consulting with its registered office in Warsaw at ul. Narbutta 83 lok. 3G, 02-524 Warsaw (hereinafter: „Organizer”).

The Conference will take place on the date and at the place indicated by the Organizer.

Participation in the Conference may be registered by physicians and representatives of the Conference sponsors.

The Conference will include scientific and didactic sessions.

The Organizer reserves the right to change the Conference program.
The provisions of these Regulations constitute an integral part of the registration for participation in the Conference and are binding on all Participants.

Participation rules
The conditions for participation of doctors in the Conference are:
possession of a valid PWZ (Permission to Practice the Profession) number – does not apply to representatives of the Conference sponsors
Each doctor who meets the conditions for participation in the Conference (hereinafter: „Participant”) and takes part in the event will receive a certificate of participation in the Conference.
The Participant covers the cost of travel on their own.

If it turns out that a person taking part in the Conference does not meet the conditions for participation, disrupts the course of scientific and didactic sessions and makes it difficult or impossible for other participants to participate in them or otherwise violates the Regulations, the Organizer reserves the right to exclude such person from further participation in the Conference.

Complaints
All complaints from Conference Participants against the Organizer should be submitted in writing by registered mail with acknowledgement of receipt to the address of the Organizer’s registered office.
Complaints from Conference Participants may be submitted no later than within 7 days from the date of the end of the Conference.
Complaints submitted after the above-mentioned deadline will not be considered.
Each complaint should include the Participant’s name and surname, address and justification for the complaint.
The Organizer’s decision on the complaint is final.

Processing of personal data
The Participant consents to the processing of personal data for the purpose of participating in the educational event organized by 90 Consulting.*
The Participant consents to the use of telecommunications terminal equipment by 90 Consulting for commercial and direct marketing purposes, in accordance with art. 172 of the Act of 16 July 2004 – Telecommunications Law (processing for marketing purposes)*
The Participant consents to receive commercial information via electronic means of communication (in particular telephone or e-mail) within the meaning of the Act of 18 July 2002 on the provision of services by electronic means (processing for marketing purposes)*
*The administrator of personal data is 90 Consulting Radosław Lipiński, ul. Narbutta 83 lok. 3G, 02-524 Warsaw. The scope of personal data processed by the administrator includes data provided in the registration application. The legal basis for the processing of personal data is the consent granted to the processing of personal data, and in the case of processing data for marketing purposes, the legal basis for the processing is the legitimate interest pursued by the administrator in the form of direct marketing.

Personal data will be stored for the period necessary to settle the educational event and provide the participant with any conference materials (i.e. for 2 years from the end of the educational event), and in the case of consent to the processing of data for marketing purposes, until an objection to the processing of data is filed. Personal data may be disclosed to external entities, including in particular entities associated with the administrator and entities financing or co-financing the educational event.

The participant has the right to:
withdraw any of the above consents at any time; withdrawal of consent does not affect the lawfulness of the processing carried out on the basis of consent before its withdrawal,
requesting the administrator to access your personal data, rectify it, delete it or limit its processing,
reporting an objection to data processing,
transferring data,
filing a complaint to the President of the Personal Data Protection Office.
Providing personal data is voluntary, but necessary in order to participate in the above-mentioned educational event.

Final provisions
In the event that the Conference is not held for reasons beyond the control of the Organizer, the so-called „force majeure” (e.g. flood, hurricane, snowstorm or other unforeseeable or unavoidable, i.e. an event beyond the control of the Organizer), the Participant is not entitled to compensation or reimbursement of any fees related to participation in the Conference, as well as the costs of additional services commissioned to the Organizer by the Conference participants.
Any disputes that may arise from participation in the Conference will be resolved by the court competent for the Organizer’s registered office.
Completing the registration form means accepting the provisions of these Regulations, as well as compliance with the order regulations and any other arrangements made between the Participant and the Organizer.
In matters not regulated by these Regulations, the provisions of the Civil Code shall apply.
The Organizer is not responsible for the Participants’ belongings that may be lost, destroyed or stolen during the Conference.
Participants are fully financially responsible for any damage they cause, both on the premises where any activities related to the Conference are carried out, as well as in the places of accommodation.

These Regulations enter into force on 1.12.2024.

    Contact

    881 770 032

    biuro@polishliversummit.pl